BOSTON SCIENTIFIC CORP (1BSX.MI) Stock Fundamental Analysis

BIT:1BSX • US1011371077

64.4 EUR
0 (0%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

1BSX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of 1BSX get a neutral evaluation. Nothing too spectacular is happening here. 1BSX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year 1BSX was profitable.
  • In the past year 1BSX had a positive cash flow from operations.
  • Of the past 5 years 1BSX 4 years were profitable.
  • 1BSX had a positive operating cash flow in 4 of the past 5 years.
1BSX.MI Yearly Net Income VS EBIT VS OCF VS FCF1BSX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

  • 1BSX has a Return On Assets of 6.54%. This is in the better half of the industry: 1BSX outperforms 73.85% of its industry peers.
  • 1BSX's Return On Equity of 11.93% is fine compared to the rest of the industry. 1BSX outperforms 72.31% of its industry peers.
  • 1BSX has a Return On Invested Capital of 8.09%. This is in the better half of the industry: 1BSX outperforms 67.69% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1BSX is below the industry average of 9.73%.
  • The last Return On Invested Capital (8.09%) for 1BSX is above the 3 year average (6.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.54%
ROE 11.93%
ROIC 8.09%
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.59%
ROIC(5y)5.7%
1BSX.MI Yearly ROA, ROE, ROIC1BSX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 14.42%, 1BSX belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
  • 1BSX's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 19.40%, 1BSX is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • 1BSX's Operating Margin has been stable in the last couple of years.
  • With a decent Gross Margin value of 68.57%, 1BSX is doing good in the industry, outperforming 75.38% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1BSX has remained more or less at the same level.
Industry RankSector Rank
OM 19.4%
PM (TTM) 14.42%
GM 68.57%
OM growth 3Y0.91%
OM growth 5Y1.48%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.15%
GM growth 5Y-0.56%
1BSX.MI Yearly Profit, Operating, Gross Margins1BSX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1BSX is destroying value.
  • There is no outstanding debt for 1BSX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1BSX.MI Yearly Shares Outstanding1BSX.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
1BSX.MI Yearly Total Debt VS Total Assets1BSX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 4.48 indicates that 1BSX is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.48, 1BSX is doing good in the industry, outperforming 76.92% of the companies in the same industry.
  • The Debt to FCF ratio of 1BSX is 3.03, which is a good value as it means it would take 1BSX, 3.03 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 3.03, 1BSX is doing good in the industry, outperforming 72.31% of the companies in the same industry.
  • A Debt/Equity ratio of 0.48 indicates that 1BSX is not too dependend on debt financing.
  • 1BSX's Debt to Equity ratio of 0.48 is in line compared to the rest of the industry. 1BSX outperforms 47.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.03
Altman-Z 4.48
ROIC/WACC0.84
WACC9.59%
1BSX.MI Yearly LT Debt VS Equity VS FCF1BSX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 1.51 indicates that 1BSX should not have too much problems paying its short term obligations.
  • 1BSX has a Current ratio of 1.51. This is comparable to the rest of the industry: 1BSX outperforms 44.62% of its industry peers.
  • A Quick Ratio of 0.96 indicates that 1BSX may have some problems paying its short term obligations.
  • 1BSX's Quick ratio of 0.96 is on the low side compared to the rest of the industry. 1BSX is outperformed by 63.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.96
1BSX.MI Yearly Current Assets VS Current Liabilites1BSX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.51% over the past year.
  • The Earnings Per Share has been growing by 26.01% on average over the past years. This is a very strong growth
EPS 1Y (TTM)21.51%
EPS 3Y20.34%
EPS 5Y26.01%
EPS Q2Q%14.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.9%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.63% on average over the next years. This is quite good.
  • 1BSX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.66% yearly.
EPS Next Y14.83%
EPS Next 2Y14.13%
EPS Next 3Y13.68%
EPS Next 5Y13.63%
Revenue Next Year11.42%
Revenue Next 2Y11.15%
Revenue Next 3Y10.54%
Revenue Next 5Y10.66%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1BSX.MI Yearly Revenue VS Estimates1BSX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B
1BSX.MI Yearly EPS VS Estimates1BSX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.96 indicates a rather expensive valuation of 1BSX.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1BSX indicates a somewhat cheap valuation: 1BSX is cheaper than 61.54% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, 1BSX is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 21.72, the valuation of 1BSX can be described as rather expensive.
  • 1BSX's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of 1BSX to the average of the S&P500 Index (28.06), we can say 1BSX is valued slightly cheaper.
Industry RankSector Rank
PE 24.96
Fwd PE 21.72
1BSX.MI Price Earnings VS Forward Price Earnings1BSX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 63.08% of the companies in the same industry are cheaper than 1BSX, based on the Enterprise Value to EBITDA ratio.
  • 1BSX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 29.5
EV/EBITDA 24.12
1BSX.MI Per share data1BSX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of 1BSX may justify a higher PE ratio.
  • 1BSX's earnings are expected to grow with 13.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.68
PEG (5Y)0.96
EPS Next 2Y14.13%
EPS Next 3Y13.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for 1BSX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BOSTON SCIENTIFIC CORP

BIT:1BSX (2/27/2026, 7:00:00 PM)

64.4

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)04-21
Inst Owners94.07%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap95.47B
Revenue(TTM)N/A
Net Income(TTM)2.79B
Analysts85.5
Price Target107.92 (67.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.27%
Min EPS beat(2)2.49%
Max EPS beat(2)4.06%
EPS beat(4)4
Avg EPS beat(4)5.68%
Min EPS beat(4)2.49%
Max EPS beat(4)10.56%
EPS beat(8)8
Avg EPS beat(8)6.15%
EPS beat(12)12
Avg EPS beat(12)5.77%
EPS beat(16)15
Avg EPS beat(16)4.37%
Revenue beat(2)2
Avg Revenue beat(2)1.69%
Min Revenue beat(2)0.96%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)1.6%
Min Revenue beat(4)0.96%
Max Revenue beat(4)2.43%
Revenue beat(8)8
Avg Revenue beat(8)2.16%
Revenue beat(12)11
Avg Revenue beat(12)2.08%
Revenue beat(16)13
Avg Revenue beat(16)1.61%
PT rev (1m)-0.59%
PT rev (3m)-2.57%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)-0.01%
EPS NY rev (1m)0.02%
EPS NY rev (3m)1.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1%
Valuation
Industry RankSector Rank
PE 24.96
Fwd PE 21.72
P/S 5.83
P/FCF 29.5
P/OCF 24.39
P/B 4.82
P/tB N/A
EV/EBITDA 24.12
EPS(TTM)2.58
EY4.01%
EPS(NY)2.96
Fwd EY4.6%
FCF(TTM)2.18
FCFY3.39%
OCF(TTM)2.64
OCFY4.1%
SpS11.05
BVpS13.36
TBVpS-1.13
PEG (NY)1.68
PEG (5Y)0.96
Graham Number27.85
Profitability
Industry RankSector Rank
ROA 6.54%
ROE 11.93%
ROCE 10.04%
ROIC 8.09%
ROICexc 8.38%
ROICexgc 28.19%
OM 19.4%
PM (TTM) 14.42%
GM 68.57%
FCFM 19.76%
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.59%
ROIC(5y)5.7%
ROICexc(3y)6.75%
ROICexc(5y)5.93%
ROICexgc(3y)22.84%
ROICexgc(5y)19.53%
ROCE(3y)8.18%
ROCE(5y)7.08%
ROICexgc growth 3Y9.18%
ROICexgc growth 5Y7.17%
ROICexc growth 3Y4.96%
ROICexc growth 5Y5.6%
OM growth 3Y0.91%
OM growth 5Y1.48%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.15%
GM growth 5Y-0.56%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.03
Debt/EBITDA 2.18
Cap/Depr 59.36%
Cap/Sales 4.14%
Interest Coverage 250
Cash Conversion 90.6%
Profit Quality 136.98%
Current Ratio 1.51
Quick Ratio 0.96
Altman-Z 4.48
F-Score6
WACC9.59%
ROIC/WACC0.84
Cap/Depr(3y)57.82%
Cap/Depr(5y)54.13%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.85%
Profit Quality(3y)134.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.51%
EPS 3Y20.34%
EPS 5Y26.01%
EPS Q2Q%14.29%
EPS Next Y14.83%
EPS Next 2Y14.13%
EPS Next 3Y13.68%
EPS Next 5Y13.63%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.9%
Revenue Next Year11.42%
Revenue Next 2Y11.15%
Revenue Next 3Y10.54%
Revenue Next 5Y10.66%
EBIT growth 1Y30.66%
EBIT growth 3Y13.12%
EBIT growth 5Y10.92%
EBIT Next Year37.52%
EBIT Next 3Y20.65%
EBIT Next 5Y17.42%
FCF growth 1Y125.15%
FCF growth 3Y26.15%
FCF growth 5Y16.61%
OCF growth 1Y96.47%
OCF growth 3Y22.44%
OCF growth 5Y13.34%

BOSTON SCIENTIFIC CORP / 1BSX.MI FAQ

What is the ChartMill fundamental rating of BOSTON SCIENTIFIC CORP (1BSX.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1BSX.MI.


What is the valuation status for 1BSX stock?

ChartMill assigns a valuation rating of 3 / 10 to BOSTON SCIENTIFIC CORP (1BSX.MI). This can be considered as Overvalued.


What is the profitability of 1BSX stock?

BOSTON SCIENTIFIC CORP (1BSX.MI) has a profitability rating of 6 / 10.


What are the PE and PB ratios of BOSTON SCIENTIFIC CORP (1BSX.MI) stock?

The Price/Earnings (PE) ratio for BOSTON SCIENTIFIC CORP (1BSX.MI) is 24.96 and the Price/Book (PB) ratio is 4.82.


What is the expected EPS growth for BOSTON SCIENTIFIC CORP (1BSX.MI) stock?

The Earnings per Share (EPS) of BOSTON SCIENTIFIC CORP (1BSX.MI) is expected to grow by 14.83% in the next year.